L.I.A. Pure Capital Ltd → Evogene Ltd. EVGN

On July 10, 2026, the Reporting Persons delivered a letter to the Issuer demanding that the Issuer convene a special general meeting of shareholders. In such letter, the Reporting Persons requested that the agenda of the special general meeting include proposals to (i) remove the current members of the Issuer's board of directors other than Mr. Ofer Haviv, (ii) elect the Reporting Persons' nominees to the Issuer's board of directors and (iii) approve compensation, exemption, indemnification and insurance arrangements for such nominees. A copy of the letter is attached hereto as Exhibit 2. The Reporting Persons believe that changes to the composition of the Issuer's board of directors are necessary in order to enhance shareholder value and improve oversight of the Issuer's business and operations. The Reporting Persons intend to engage in discussions with the Issuer's board of directors, management, shareholders and other interested parties regarding the foregoing matters and may take such actions as they determine appropriate in connection therewith, including seeking shareholder support for the proposals described above.